In healthy users at typical biohacking doses: Injection site irritation is possible Mild headaches in the first few days (common, typically resolves) Vivid dreams (normal, sign of neuroplasticity activity) Rare: overstimulation/anxiety at higher doses back off if this occurs Because it contains amino acids that include excitatory neurotransmitter precursors, people with seizure history should approach cautiously and consult a physician
Sauzet, O., Carvajal, A., Escudero, A., Molokhia, M
& Cariappa, A
diagnosis diagnosis There are a variety of approaches, which may depend on local resources and pre-test probability
According to the American Medical Association (AMA), US spending on GLP-1 drugs grew from US$3.1 billion in 2019 to US$27 billion in 2022 an almost nine-fold increase driven largely by off-label use for weight loss